Advertisement

Topics

Faron Pharmaceuticals garners some encouragement from phase III data; still searching for answers to key questions

03:34 EDT 14 Jun 2018 | Proactive Investors

It has discovered that a sub-group of patients with higher levels of certain bio-markers showed a reduced mortality rate and increased ventilator-free days

Original Article: Faron Pharmaceuticals garners some encouragement from phase III data; still searching for answers to key questions

NEXT ARTICLE

More From BioPortfolio on "Faron Pharmaceuticals garners some encouragement from phase III data; still searching for answers to key questions"

Advertisement
Quick Search
Advertisement
Advertisement